{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:58:53Z","timestamp":1790650733800,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semradonc.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.semradonc.2015.02.009","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:53:21Z","timestamp":1424739201000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical Management of Seizures in Patients With Low-Grade Glioma"],"prefix":"10.1016","volume":"25","author":[{"given":"Anna F.","family":"Piotrowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semradonc.2015.02.009_bib1","first-page":"479","article-title":"Epilepsy and gliomas: Incidence and treatment in 119 patients","volume":"17","author":"Pace","year":"1998","journal-title":"J Exp Clin Cancer Res"},{"issue":"Suppl 9","key":"10.1016\/j.semradonc.2015.02.009_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12437","article-title":"Seizure characteristics and prognostic factors of gliomas","volume":"54","author":"Kerkhof","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jocn.2014.05.036","article-title":"Epilepsy in patients with gliomas: Incidence and control of seizures","volume":"22","author":"Iuchi","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1016\/j.semradonc.2015.02.009_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1684\/epd.2008.0161","article-title":"Epilepsia partialis continua: Semiology and differential diagnosis","volume":"10","author":"Bien","year":"2008","journal-title":"Epileptic Disord"},{"issue":"Suppl 4","key":"10.1016\/j.semradonc.2015.02.009_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: Natural history, pathogenesis, and outcome after treatments","volume":"14","author":"Ruda","year":"2012","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000052089","article-title":"Seizure disorders in patients with brain tumors","volume":"45","author":"Liigant","year":"2001","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.semradonc.2015.02.009_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.semradonc.2015.02.009_bib9","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/01.WNL.0000031432.05543.14","article-title":"Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury: Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"60","author":"Chang","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semradonc.2015.02.009_bib11","first-page":"CD004424","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumors","author":"Tremont-Lukats","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.semradonc.2015.02.009_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3171\/2011.3.JNS1153","article-title":"Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg"},{"issue":"9490","key":"10.1016\/j.semradonc.2015.02.009_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.semradonc.2015.02.009_bib14","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/neuonc\/not109","article-title":"Seizure control following radiotherapy in patients with diffuse gliomas: A retrospective study","volume":"15","author":"Ruda","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semradonc.2015.02.009_bib15","article-title":"Seizure reduction in a low-grade glioma: More than a beneficial side effect of temozolomide","author":"Koekkoek","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.semradonc.2015.02.009_bib16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3171\/2010.12.JNS101602","article-title":"Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas","volume":"114","author":"Sherman","year":"2011","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.semradonc.2015.02.009_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/annonc\/mdg371","article-title":"Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas","volume":"14","author":"Brada","year":"2003","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2015.02.009_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.semradonc.2015.02.009_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/neuonc\/not170","article-title":"Levetiracetam and pregabalin or antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study","volume":"16","author":"Rossetti","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","article-title":"Levetiracetam monotherapy in patients with brain tumor-related epilepsy: Seizure control, safety, and quality of life","volume":"104","author":"Maschio","year":"2011","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.semradonc.2015.02.009_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","article-title":"Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: A randomized phase II pilot study","volume":"93","author":"Lim","year":"2009","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.semradonc.2015.02.009_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2015.02.009_bib23","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semradonc.2015.02.009_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clineuro.2008.09.009","article-title":"Pregabalin in patients with primary brain tumors and seizures: A preliminary observation","volume":"111","author":"Novy","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.semradonc.2015.02.009_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: New insights and evidence-based management","volume":"19","author":"Vecht","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.semradonc.2015.02.009_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1528-1167.2010.02929.x","article-title":"Remission and relapse in a drug-resistant epilepsy population followed prospectively","volume":"52","author":"Callaghan","year":"2011","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.semradonc.2015.02.009_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/2013.3.JNS121890","article-title":"Efficacy of vagus nerve stimulation in brain tumor-associated intractable epilepsy and the importance of tumor stability","volume":"119","author":"Patel","year":"2013","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.semradonc.2015.02.009_bib28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: A pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Reiger","year":"2014","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2015.02.009_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J Neurooncol"},{"issue":"2 Pt A","key":"10.1016\/j.semradonc.2015.02.009_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.canlet.2014.07.015","article-title":"Metabolic therapy: A new paradigm for managing malignant brain cancer","volume":"356","author":"Seyfried","year":"2015","journal-title":"Cancer Lett"},{"issue":"1-2","key":"10.1016\/j.semradonc.2015.02.009_bib31","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/j.wneu.2014.02.033","article-title":"Management of low-grade gliomas: A review of patient-perceived quality of life and neurocognitive outcome","volume":"82","author":"Shields","year":"2014","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.semradonc.2015.02.009_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","article-title":"Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life","volume":"54","author":"Klein","year":"2003","journal-title":"Ann Neurol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429615000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429615000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T10:53:34Z","timestamp":1717757614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429615000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1053429615000260"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2015.02.009","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Management of Seizures in Patients With Low-Grade Glioma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2015.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}